Moisand Fitzgerald Tamayo’s Pfizer PFE Stock Holding History

Moisand Fitzgerald Tamayo’s Portfolio PFE Stock Details PFE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$187K	Hold	7,751	–	–	0.02%	126
2026 Q1	$218K	Hold	7,751	–	–	0.02%	113
2025 Q4	$193K	Hold	7,751	–	–	0.02%	119
2025 Q3	$198K	Sell	7,751 -150	-2%	-$3.7K	0.02%	121
2025 Q2	$192K	Hold	7,901	–	–	0.02%	121
2025 Q1	$200K	Buy	7,901 +150	+2%	+$3.92K	0.03%	111
2024 Q4	$206K	Sell	7,751 -8	-0.1%	-$217	0.03%	111
2024 Q3	$225K	Buy	7,759 +10	+0.1%	+$292	0.03%	106
2024 Q2	$217K	Hold	7,749	–	–	0.03%	103
2024 Q1	$215K	Sell	7,749 -271	-3%	-$7.52K	0.03%	102
2023 Q4	$231K	Sell	8,020 -805	-9%	-$24.3K	0.04%	94
2023 Q3	$293K	Buy	8,825 +195	+2%	+$6.9K	0.06%	84
2023 Q2	$317K	Hold	8,630	–	–	0.06%	83
2023 Q1	$352K	Sell	8,630 -345	-4%	-$14.9K	0.08%	79
2022 Q4	$460K	Buy	8,975 +477	+6%	+$22.9K	0.1%	70
2022 Q3	$372K	Buy	8,498 +719	+9%	+$34.9K	0.1%	73
2022 Q2	$408K	Buy	7,779 +7,434	+2,155%	+$379K	0.11%	73
2022 Q1	$18K	Sell	345 -7,434	-96%	-$386K	0.01%	144
2021 Q4	$459K	Hold	7,779	–	–	0.13%	66
2021 Q3	$335K	Buy	7,779 +345	+5%	+$15.3K	0.11%	70
2021 Q2	$291K	Sell	7,434 -125	-2%	-$4.86K	0.11%	72
2021 Q1	$274K	Sell	7,559 -500	-6%	-$17.8K	0.12%	68
2020 Q4	$297K	Sell	8,059 -1,015	-11%	-$37.2K	0.13%	63
2020 Q3	$316K	Hold	9,074	–	–	0.16%	59
2020 Q2	$282K	Sell	9,074 -411	-4%	-$14K	0.16%	59
2020 Q1	$294K	Sell	9,485 -29	-0.3%	-$988	0.19%	59
2019 Q4	$354K	Buy	9,514 +29	+0.3%	+$1.03K	0.18%	56
2019 Q3	$323K	Hold	9,485	–	–	0.17%	57
2019 Q2	$390K	Sell	9,485 -532	-5%	-$21.1K	0.21%	55
2019 Q1	$404K	Buy	10,017 +532	+6%	+$21.3K	0.22%	55
2018 Q4	$393K	Sell	9,485 -1,278	-12%	-$53.1K	0.25%	54
2018 Q3	$450K	Hold	10,763	–	–	0.25%	53
2018 Q2	$370K	Sell	10,763 -264	-2%	-$9.02K	0.22%	55
2018 Q1	$371K	Buy	11,027 +264	+2%	+$9.08K	0.22%	55
2017 Q4	$370K	Sell	10,763 -48	-0.4%	-$1.64K	0.21%	48
2017 Q3	$366K	Buy	+10,811	New	+$347K	0.22%	50
2016 Q2	–	Sell	-2,145	Closed	-$60K	–	155
2016 Q1	$60K	Hold	2,145	–	–	0.05%	89
2015 Q4	$66K	Buy	+2,145	New	+$67.5K	0.06%	79

Other funds holding PFE

Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return

CWP

Curated Wealth Partners El Segundo, California $774M AUM 5.71% 1-Year Est. Return

Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return

Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return

FWIA

Fort Washington Investment Advisors Cincinnati, Ohio $19.9B AUM 22.19% 1-Year Est. Return

ORIO

Old Republic International (ORI) Chicago, Illinois $2.67B AUM 26.94% 1-Year Est. Return

CNB

Czech National Bank Prague, Czech Republic $18.3B AUM 43.04% 1-Year Est. Return

Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 51.91% 1-Year Est. Return

Moisand Fitzgerald Tamayo's PFE Position: Q2 2026 in Review

Moisand Fitzgerald Tamayo held its Pfizer (PFE) position steady in Q2 2026 at 7,751 shares worth $187K. The position accounts for 0.02% of the portfolio, ranked #126.

Moisand Fitzgerald Tamayo first reported a position in PFE in Q4 2015 and has held it in 38 quarters since. The position peaked at $460K in Q4 2022. 672 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

Moisand Fitzgerald Tamayo held 7,751 shares of Pfizer worth $187K as of Q2 2026.
Moisand Fitzgerald Tamayo left its Pfizer share count unchanged in Q2 2026.
Pfizer made up 0.02% of Moisand Fitzgerald Tamayo's portfolio in Q2 2026, its #126 holding.
Moisand Fitzgerald Tamayo first reported a position in Pfizer in Q4 2015 and has held it in 38 quarters since.
Moisand Fitzgerald Tamayo's Pfizer position peaked at $460K in Q4 2022.
672 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on Moisand Fitzgerald Tamayo's 13F filing for Q2 2026, filed 13 Jul 2026.